Literature DB >> 6682282

Hypertrophic obstructive cardiomyopathy: ten- to 21-year follow-up after partial septal myectomy.

M M Beahrs, A J Tajik, J B Seward, E R Giuliani, D C McGoon.   

Abstract

This study reviews the outcome in 36 consecutive patients who survived partial septal myectomy for hypertrophic obstructive cardiomyopathy operated on between 1960 and 1972. All patients were followed up until death or until June 1981 (mean 13.4 years). Of the 26 survivors, 17 had been more than mildly symptomatic preoperatively, but only 1 remained so postoperatively. The operation was effective in relieving the obstruction (peak systolic pressure gradient reduced from 79 to 8 mm Hg [p less than 0.001]), and mitral regurgitation was relieved. No survivor's symptoms worsened, but 10 died late--4 suddenly, 5 from congestive heart failure, and 1 from a malignancy. The 10-year survival rate was 77%. No correlation with outcome was found with respect to age, surgical approach, preoperative functional class, pressure gradient, left ventricular end-diastolic pressure, or presence of atrial fibrillation, but atrial fibrillation occurring late postoperatively (12 patients) was associated with an increased frequency of late death (7 of 10 late deaths) or continuing New York Heart Association functional class III status. Early or late postoperative complete heart block occurred in 1 patient each. Thus, these results suggest a favorable effect of operation and support continued surgical intervention for appropriate patients.

Entities:  

Mesh:

Year:  1983        PMID: 6682282     DOI: 10.1016/0002-9149(83)90363-6

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  4 in total

1.  Non-surgical ablation of the ventricular septum for the treatment of hypertrophic cardiomyopathy.

Authors:  C M Oakley
Journal:  Br Heart J       Date:  1995-11

Review 2.  The "1st septal unit" in hypertrophic obstructive cardiomyopathy: a newly recognized anatomo-functional entity, identified during recent alcohol septal ablation experience.

Authors:  Paolo Angelini
Journal:  Tex Heart Inst J       Date:  2007

3.  Progression of hypertrophic cardiomyopathy. A cross sectional echocardiographic study.

Authors:  S Domenicucci; E Lazzeroni; J Roelandt; F J ten Cate; W B Vletter; A C Arntzenius; S K Das
Journal:  Br Heart J       Date:  1985-04

Review 4.  Percutaneous transluminal septal myocardial ablation.

Authors:  D N Rubin; E M Tuzcu; H M Lever
Journal:  Curr Cardiol Rep       Date:  2000-03       Impact factor: 3.955

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.